Results 111 to 120 of about 20,805 (196)

ADAM17 blockade restores natural killer cell antibody-dependent cytotoxicity against human immunodeficiency virus-1. [PDF]

Virol J
Sugawara S, Jost S, Woolley G, Reeves RK.   +3 more
europepmc   +1 more source

Chronic chikungunya is associated with decreased anti-CHIKV antibody titers, neutralizing capacity, and antibody-dependent cellular cytotoxicity. [PDF]

iScience
Upasani V, Lay S, Heng S, Maestri A, Ken S, Sorn S, Leang R, Ly S, Duong V, Cantaert T.   +9 more
europepmc   +1 more source

Tuberculosis treatment and cytotoxic immune signatures: a longitudinal study. [PDF]

J Clin Tuberc Other Mycobact Dis
Sulca C, Piamonte A, Quispe-Ricalde MA, Delgado S, Albornoz SP, Tuero I.   +5 more
europepmc   +1 more source

Catch me if you can! Is there protection from HCV (re)infection? [PDF]

Gut
Bartosch B, Lauer GM.
europepmc   +1 more source

The Role of Natural Killer (NK) Cells in Dengue Virus Infection: A Narrative Review. [PDF]

Health Sci Rep
Islam F.
europepmc   +1 more source

Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils. [PDF]

Cells
Holtrop T, van der Peet IC, Hendriks IST, Kardol-Hoefnagel T, Schol RB, Lustig M, Budding K, Leusen JHW, Olofsen PA, Tsioumpekou M.   +9 more
europepmc   +1 more source

Multiple Modes of Action of Anti-TNF-α Antibodies for Inflammatory Bowel Diseases Beyond TNF-α Neutralization. [PDF]

Antibodies (Basel)
Watanabe T, Kudo M.
europepmc   +1 more source

FcεRIγ reinforces double-negative T cell-mediated antibody-dependent cellular cytotoxicity against tumor cells. [PDF]

J Mol Cell Biol
Shao S, Han X, Zhang T, Yang L, Li M, Zhang Z, Du X, Jin H, Wang S, Yang Y, Zhang Z, Sun G, Zhang D, Tian D.   +13 more
europepmc   +1 more source

Incidence and implications of anti-rituximab antibodies in nephropathies and other immune-mediated diseases: a narrative review. [PDF]

Front Immunol
Allinovi M, Lomi J, Accinno M, Teisseyre M, Diomaiuti M, Madeo R, Allegretta F, Matucci A, Vultaggio A.   +8 more
europepmc   +1 more source

EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer. [PDF]

MedComm (2020)
Xiao R, Li X, Li P, Wang J, Sun X, Zhao C, Liu Z, Gong R, Ren M, Lei K, Ren H.   +10 more
europepmc   +1 more source